Hong Kong

DLA Piper advises on Hong Kong IPO of Chinese biotech company Xuanzhu Biopharmaceutical

14 October 2025

Managing IP with Limited Resources: Smart Tactics for In-House Legal Teams

9 October 2025 .2 minute read

Security of payment: Hong Kong

8 October 2025